NCT06618027
- Conditions
- Anxiety Disorders, Autoimmune Diseases, Behavior, +11 more
- Locations
-
- Barbara Davis Center Aurora, Colorado, United States
- Children's National Hospital Washington D.C., District of Columbia, United States
Clinical trial condition
Type 1 Diabetes (T1D)
Explore clinical trials studying Type 1 Diabetes (T1D). Study availability and eligibility vary by location and protocol.
93 public trials
49 recruiting studies
Type 1 Diabetes (T1D) trial results
NCT07051564
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Zibo Central hospital Zibo, Shandong, China
NCT07021456
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +11 more
- Locations
-
- Grenoble Grenoble, France
NCT06994403
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
- Locations
-
- Federico II University Naples, Italy
NCT06984133
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
- Locations
-
- Dasman Diabetes Institute Kuwait City, Sharq, Kuwait
NCT06918444
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +12 more
- Locations
-
- Instituto Universitario De Investigaciones Biomédicas y Sanitarias (IUIBS) Las Palmas de Gran Canaria, Las Palmas, Spain
NCT06804694
- Conditions
- Autoimmune Diseases, Diabetes Distress, Diabetes Mellitus, +7 more
- Locations
-
- Centre for Addiction and Mental Health Toronto, Ontario, Canada
NCT06717893
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
Recruiting
Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients with Type 1 Diabetes (T1D)
NCT06315725
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +9 more
- Locations
-
- Center for Innovative Medicine, The Research Institute of the McGill University Health Centre Montreal, Quebec, Canada
Not yet recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
NCT07616206
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Atlanta Diabetes Associates Atlanta, Georgia, United States